Shares of Haemonetics Co. (NYSE:HAE) have been given an average rating of “Buy” by the six ratings firms that are currently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year target price among […]
